{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:12:17Z","timestamp":1778591537797,"version":"3.51.4"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB970"],"award-info":[{"award-number":["2023AFB970"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["WZ21A08"],"award-info":[{"award-number":["WZ21A08"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["WX23Z40"],"award-info":[{"award-number":["WX23Z40"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["WHRCH202304"],"award-info":[{"award-number":["WHRCH202304"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2018YFC1314700"],"award-info":[{"award-number":["2018YFC1314700"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873782"],"award-info":[{"award-number":["81873782"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["WX18A10"],"award-info":[{"award-number":["WX18A10"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020020601012303"],"award-info":[{"award-number":["2020020601012303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.smrv.2025.102181","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:49:14Z","timestamp":1759340954000},"page":"102181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Botulinum toxin therapy for neurological disorders: Serendipitous benefits on sleep quality and underlying mechanisms"],"prefix":"10.1016","volume":"84","author":[{"given":"Guiying","family":"Kuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danfang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanshu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsha","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison J.","family":"Cash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.smrv.2025.102181_bib1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41577-019-0190-z","article-title":"Sleep and inflammation: partners in sickness and in health","volume":"19","author":"Irwin","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41574-022-00747-7","article-title":"The role of insufficient sleep and circadian misalignment in obesity","volume":"19","author":"Chaput","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.smrv.2025.102181_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.cpr.2012.07.003","article-title":"Overlapping prefrontal systems involved in cognitive and emotional processing in euthymic bipolar disorder and following sleep deprivation: a review of functional neuroimaging studies","volume":"32","author":"McKenna","year":"2012","journal-title":"Clin Psychol Rev"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jsmc.2022.02.001","article-title":"Sleep and cognition: a narrative review focused on older adults","volume":"17","author":"Dzierzewski","year":"2022","journal-title":"Sleep Med Clin"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jsmc.2016.10.007","article-title":"Neurologic diseases and sleep","volume":"12","author":"Barone","year":"2017","journal-title":"Sleep Med Clin"},{"issue":"11","key":"10.1016\/j.smrv.2025.102181_bib6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2165\/11537390-000000000-00000","article-title":"Economic implications of sleep disorders","volume":"28","author":"Skaer","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.smrv.2025.102181_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-psych-010213-115205","article-title":"Why sleep is important for health: a psychoneuroimmunology perspective","volume":"66","author":"Irwin","year":"2015","journal-title":"Annu Rev Psychol"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jsmc.2015.10.007","article-title":"Sleep duration and cardiovascular disease risk: Epidemiologic and experimental evidence","volume":"11","author":"Covassin","year":"2016","journal-title":"Sleep Med Clin"},{"issue":"5","key":"10.1016\/j.smrv.2025.102181_bib9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition: highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"issue":"10357","key":"10.1016\/j.smrv.2025.102181_bib10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(22)00879-0","volume":"400","author":"Perlis","year":"2022","journal-title":"Insomnia Lancet (London, England)"},{"key":"10.1016\/j.smrv.2025.102181_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2023.101892","article-title":"Acupuncture for primary insomnia: effectiveness, safety, mechanisms and recommendations for clinical practice","volume":"74","author":"Zhao","year":"2024","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2025.102181_bib12","article-title":"Obstructive sleep apnoea syndrome","volume":"1","author":"L\u00e9vy","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib13","article-title":"Long-term management of sleep apnea-hypopnea syndrome: efficacy and challenges of continuous positive airway pressure Therapy-A narrative review","volume":"13","author":"Rahman","year":"2024","journal-title":"Med Sci(Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib14","article-title":"Pharmacotherapy for insomnia in primary care","volume":"18","author":"Smith","year":"2016","journal-title":"Primary Care Companion CNS Disorders"},{"key":"10.1016\/j.smrv.2025.102181_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2022.101735","article-title":"Repetitive transcranial magnetic stimulation in primary sleep disorders","volume":"67","author":"Lanza","year":"2023","journal-title":"Sleep Med Rev"},{"issue":"5","key":"10.1016\/j.smrv.2025.102181_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cpr.2005.04.003","article-title":"Cognitive-behavioral therapy for primary insomnia","volume":"25","author":"Edinger","year":"2005","journal-title":"Clin Psychol Rev"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol Rev"},{"issue":"Suppl 8","key":"10.1016\/j.smrv.2025.102181_bib18","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/mds.20010","article-title":"Different types of botulinum toxin in humans","volume":"19","author":"Eleopra","year":"2004","journal-title":"Mov Disord : J Movement Disor Soc"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00702-020-02266-z","article-title":"Botulinum toxin therapy of dystonia","volume":"128","author":"Dressler","year":"2021","journal-title":"J Neural Transm"},{"issue":"5","key":"10.1016\/j.smrv.2025.102181_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40265-018-0894-6","article-title":"OnabotulinumtoxinA: a review in the prevention of chronic migraine","volume":"78","author":"Frampton","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14010036","article-title":"A systematic review and meta-analysis of efficacy of botulinum toxin A for neuropathic pain","volume":"14","author":"Datta Gupta","year":"2022","journal-title":"Toxins"},{"issue":"11","key":"10.1016\/j.smrv.2025.102181_bib22","article-title":"Botulinum toxin type A therapy for hemifacial spasm","volume":"11","author":"Duarte","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.smrv.2025.102181_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/toxins16090392","article-title":"Use of botulinum toxin in upper-limb tremor: systematic review and perspectives","volume":"16","author":"Motavasseli","year":"2024","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib24","article-title":"Botulinum toxin for motor and phonic tics in Tourette's syndrome","volume":"1","author":"Pandey","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.smrv.2025.102181_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14110734","article-title":"AbobotulinumtoxinA doses in upper and lower limb spasticity: a systematic literature review","volume":"14","author":"Schnitzler","year":"2022","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.semarthrit.2011.07.006","article-title":"Botulinum toxin A treatment of Raynaud's phenomenon: a review","volume":"41","author":"Iorio","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/toxins16020096","article-title":"From toxin to treatment: a narrative review on the use of botulinum toxin for autonomic dysfunction","volume":"16","author":"Rempel","year":"2024","journal-title":"Toxins"},{"issue":"7","key":"10.1016\/j.smrv.2025.102181_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8070201","article-title":"Botulinum toxin A for bladder pain syndrome\/interstitial cystitis","volume":"8","author":"Chiu","year":"2016","journal-title":"Toxins"},{"issue":"10","key":"10.1016\/j.smrv.2025.102181_bib29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s40265-013-0068-5","article-title":"Efficacy and safety of botulinum toxin A intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic review","volume":"73","author":"Soljanik","year":"2013","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.smrv.2025.102181_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/jnnp-2020-325546","article-title":"Sleep disturbance in movement disorders: insights, treatments and challenges","volume":"92","author":"Bailey","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.smrv.2025.102181_bib31","first-page":"275","article-title":"Successful treatment of recalcitrant restless legs syndrome with botulinum toxin type-A","volume":"2","author":"Rotenberg","year":"2006","journal-title":"J Clin Sleep Med : JCSM : Official Pub Am Acad Sleep Med"},{"issue":"3","key":"10.1016\/j.smrv.2025.102181_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12030168","article-title":"Botulinum toxin therapy for managing sleep bruxism: a randomized and placebo-controlled trial","volume":"12","author":"Shim","year":"2020","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib33","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3892\/etm.2017.4612","article-title":"Ultrasound guided injections of botulinum toxin type A into stellate ganglion to treat insomnia","volume":"14","author":"Ding","year":"2017","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib34","first-page":"431","article-title":"The effect of botulinum toxin in the masticatory and constrictor musculature of the pharynx as an option in the treatment of obstructive sleep apnea: a case report","volume":"21","author":"Ottoline","year":"2025","journal-title":"J Clin Sleep Med : JCSM : Official Pub Am Acad Sleep Med"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib35","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1590\/S0004-282X2006000600028","article-title":"Botulinum-A toxin in the treatment of painful post-stroke nocturnal paroxysmal dystonia triggered by periodic limb movements of sleep: case report","volume":"64","author":"Kowacs","year":"2006","journal-title":"Arquivos de neuro-psiquiatria"},{"issue":"9","key":"10.1016\/j.smrv.2025.102181_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9090260","article-title":"Botulinum toxin for the treatment of neuropathic pain","volume":"9","author":"Park","year":"2017","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41572-021-00328-4","article-title":"Migraine","volume":"8","author":"Ferrari","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.smrv.2025.102181_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00702-015-1453-x","article-title":"Strategies for treatment of dystonia","volume":"123","author":"Dressler","year":"2016","journal-title":"J Neural Transm"},{"issue":"11","key":"10.1016\/j.smrv.2025.102181_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008624.pub2","article-title":"Interventions for drooling in children with cerebral palsy","volume":"11","author":"Walshe","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.smrv.2025.102181_bib42","first-page":"99","article-title":"The effects of botulinum toxin type A injection on pain symptoms, quality of life, and sleep quality of patients with diabetic neuropathy: a randomized double-blind clinical trial","volume":"18","author":"Salehi","year":"2019","journal-title":"Iranian J Neuro"},{"key":"10.1016\/j.smrv.2025.102181_bib43","first-page":"2022","article-title":"Efficacy and safety of botulinum toxin A and pulsed radiofrequency on postherpetic neuralgia: a randomized clinical trial","author":"Chen","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/00207454.2015.1019624","article-title":"Botulinum toxin A in the treatment of trigeminal neuralgia","volume":"126","author":"Xia","year":"2016","journal-title":"Int J Neurosci"},{"issue":"17","key":"10.1016\/j.smrv.2025.102181_bib45","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.smrv.2025.102181_bib46","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1526-4637.2010.01003.x","article-title":"Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia","volume":"11","author":"Xiao","year":"2010","journal-title":"Pain Med"},{"issue":"10","key":"10.1016\/j.smrv.2025.102181_bib47","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/AJP.0b013e31827a72d2","article-title":"Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial","volume":"29","author":"Apalla","year":"2013","journal-title":"Clin J Pain"},{"issue":"6","key":"10.1016\/j.smrv.2025.102181_bib48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(16)00017-X","article-title":"Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Attal","year":"2016","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.smrv.2025.102181_bib49","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.PHM.0000124444.32257.04","article-title":"Effects of botulinum toxin type B on stump pain and involuntary movements of the stump","volume":"83","author":"Kern","year":"2004","journal-title":"Am J Phys Med Rehab"},{"key":"10.1016\/j.smrv.2025.102181_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41394-019-0221-9","article-title":"Treatment of at-level spinal cord injury pain with botulinum toxin A","volume":"5","author":"Chun","year":"2019","journal-title":"Spinal Cord Ser Cases"},{"key":"10.1016\/j.smrv.2025.102181_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3284446","article-title":"Botox (OnabotulinumtoxinA) for treatment of migraine symptoms: a systematic review","volume":"2022","author":"Shaterian","year":"2022","journal-title":"Pain Res Manag"},{"issue":"6","key":"10.1016\/j.smrv.2025.102181_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.950","article-title":"What is the actual prevalence of migraine?","volume":"8","author":"Yeh","year":"2018","journal-title":"Brain Behav"},{"issue":"3","key":"10.1016\/j.smrv.2025.102181_bib53","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp-2018-319290","article-title":"Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety","volume":"90","author":"Blumenfeld","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.smrv.2025.102181_bib54","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1526-4610.2007.00953.x","article-title":"Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues","volume":"48","author":"Cady","year":"2008","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1526-4610.2010.01796.x","article-title":"A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine","volume":"51","author":"Cady","year":"2011","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.smrv.2025.102181_bib56","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1590\/0004-282x20180109","article-title":"Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison","volume":"76","author":"Loeb","year":"2018","journal-title":"Arquivos de neuro-psiquiatria"},{"key":"10.1016\/j.smrv.2025.102181_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-017-0723-4","article-title":"OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study","volume":"18","author":"Aydinlar","year":"2017","journal-title":"J Headache Pain"},{"issue":"9","key":"10.1016\/j.smrv.2025.102181_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15090527","article-title":"Effects of a single session of OnabotulinumtoxinA therapy on sleep quality and psychological measures: preliminary findings in a population of chronic migraineurs","volume":"15","author":"Torrente","year":"2023","journal-title":"Toxins"},{"issue":"1\u20132","key":"10.1016\/j.smrv.2025.102181_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000499764","article-title":"Effects of botulinum toxin A on Allodynia in chronic migraine: an observational open-label two-year study","volume":"81","author":"de Tommaso","year":"2019","journal-title":"Eur Neurol"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00702-021-02314-2","article-title":"Dystonia updates: definition, nomenclature, clinical classification, and etiology","volume":"128","author":"Gr\u00fctz","year":"2021","journal-title":"J Neural Transm"},{"issue":"14","key":"10.1016\/j.smrv.2025.102181_bib61","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/mds.25244","article-title":"The prevalence of primary dystonia: a systematic review and meta-analysis","volume":"27","author":"Steeves","year":"2012","journal-title":"Mov Disord : J Movement Disor Soc"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002826-200007000-00006","article-title":"A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis","volume":"23","author":"Brefel-Courbon","year":"2000","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.smrv.2025.102181_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13800","article-title":"Quality of life improvements in patients with cervical dystonia following treatment with a liquid formulation of abobotulinumtoxinA (dysport(\u00ae))","volume":"26","author":"Simonetta-Moreau","year":"2019","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.smrv.2025.102181_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13090647","article-title":"Effect of botulinum toxin on non-motor symptoms in cervical dystonia","volume":"13","author":"Costanzo","year":"2021","journal-title":"Toxins"},{"issue":"12","key":"10.1016\/j.smrv.2025.102181_bib65","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1007\/s00417-023-06141-x","article-title":"Relations between nonmotor manifestations and motor disorders in patients with benign essential blepharospasm","volume":"261","author":"Zhou","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib66","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0043-1767753","article-title":"Blepharospasm patients after botulinum toxin - sleep approach","volume":"16","author":"Lestingi","year":"2023","journal-title":"Sleep Sci"},{"issue":"10","key":"10.1016\/j.smrv.2025.102181_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14100656","article-title":"Effects of botulinum toxin therapy on health-related quality of life evaluated by the oromandibular dystonia rating scale","volume":"14","author":"Yoshida","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.smrv.2025.102181_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1115482","article-title":"Effect of botulinum toxin type A on non-motor symptoms and quality of life in meige syndrome","volume":"14","author":"Zheng","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.smrv.2025.102181_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.prdoa.2022.100142","article-title":"Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: phase 4, open-label, randomized, noninferiority study","volume":"6","author":"Comella","year":"2022","journal-title":"Clin Parkinson Related Disorders"},{"issue":"1\u20132","key":"10.1016\/j.smrv.2025.102181_bib70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2014.12.030","article-title":"Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE)","volume":"349","author":"Jankovic","year":"2015","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5603\/PJNNS.a2023.0042","article-title":"KinesioTaping: impact on non-motor symptoms in cervical dystonia patients treated with botulinum toxin injection","volume":"58","author":"Dec-Cwiek","year":"2024","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-10802-y","article-title":"Impairment of sleep homeostasis in cervical dystonia patients","volume":"12","author":"Caverzasio","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.smrv.2025.102181_bib73","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s13760-025-02742-x","article-title":"Assessment of quality of life in patients with cervical dystonia and hemifacial spasm after botulinum toxin injections","volume":"125","author":"Elshebawy","year":"2025","journal-title":"Acta Neurol Belg"},{"issue":"6","key":"10.1016\/j.smrv.2025.102181_bib74","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jnnp.68.6.707","article-title":"Botulinum toxin (dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study","volume":"68","author":"Hyman","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib75","doi-asserted-by":"crossref","first-page":"331","DOI":"10.17712\/nsj.2016.4.20160207","article-title":"Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers sleep quality and depression","volume":"21","author":"Binay Safer","year":"2016","journal-title":"Neurosciences"},{"issue":"8","key":"10.1016\/j.smrv.2025.102181_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11080453","article-title":"Association of long-term treatment by botulinum neurotoxins and occupational therapy with subjective physical status in patients with post-stroke hemiplegia","volume":"11","author":"Hamaguchi","year":"2019","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.smrv.2025.102181_bib77","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1468-1331.2001.00277.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke","volume":"8","author":"Bakheit","year":"2001","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000069495","article-title":"A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (dysport) in the treatment of spastic equinovarus deformity after stroke","volume":"15","author":"Pittock","year":"2003","journal-title":"Cerebrovasc Dis"},{"issue":"10","key":"10.1016\/j.smrv.2025.102181_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105160","article-title":"Evaluation of the effectiveness of treatment with botulinum toxin on sleep quality in stroke-related spasticity","volume":"29","author":"Deveci","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40120-019-00155-6","article-title":"Therapy of sialorrhea with botulinum neurotoxin","volume":"8","author":"Jost","year":"2019","journal-title":"Neurol Ther"},{"issue":"5","key":"10.1016\/j.smrv.2025.102181_bib81","article-title":"Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis","volume":"5","author":"James","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib82","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11910-014-0511-3","article-title":"An update on the use of botulinum toxin therapy in parkinson's disease","volume":"15","author":"Mills","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib83","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/SCS.0b013e31827102a0","article-title":"Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling","volume":"24","author":"Reid","year":"2013","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.smrv.2025.102181_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fresc.2022.875235","article-title":"Comparative efficacy of botulinum toxin in salivary glands vs. oromotor therapy in the management of sialorrhea in cerebral palsy impact on sleep quality","volume":"3","author":"Marquez-Vazquez","year":"2022","journal-title":"Front Rehabilit Sci"},{"key":"10.1016\/j.smrv.2025.102181_bib85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.smrv.2015.11.008","article-title":"Sleep disorders in children with cerebral palsy: an integrative review","volume":"30","author":"L\u00e9lis","year":"2016","journal-title":"Sleep Med Rev"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib86","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.prrv.2008.10.003","article-title":"Assessing and managing lung disease and sleep disordered breathing in children with cerebral palsy","volume":"10","author":"Fitzgerald","year":"2009","journal-title":"Paediatr Respir Rev"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib87","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ijporl.2013.01.001","article-title":"Tongue base suspension in children with cerebral palsy and obstructive sleep apnea","volume":"77","author":"Hartzell","year":"2013","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib88","first-page":"153","article-title":"Bilateral hemifacial spasm","volume":"10","author":"Holds","year":"1990","journal-title":"J Clin Neuroophthalmol"},{"issue":"11","key":"10.1016\/j.smrv.2025.102181_bib89","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archneur.1990.00530110095023","article-title":"Hemifacial spasm in Rochester and olmsted County, Minnesota, 1960 to 1984","volume":"47","author":"Auger","year":"1990","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/toxins17040173","article-title":"A 12-Week prospective, Double-blind, multicenter, randomized study comparing 100 units of abobotulinum toxin type A (dysport(\u00ae)) and 33.33 units of neubotulinum toxin type A (Neuronox(\u00ae)) for the treatment of hemifacial spasm","volume":"17","author":"Kongsaengdao","year":"2025","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib91","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1756285616682676","article-title":"Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasm","volume":"10","author":"Weiss","year":"2017","journal-title":"Therapeutic Adv Neurol Disorders"},{"issue":"5","key":"10.1016\/j.smrv.2025.102181_bib92","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.eururo.2013.10.033","article-title":"An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders","volume":"65","author":"Mangera","year":"2014","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.smrv.2025.102181_bib93","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrurol.2015.193","article-title":"Current and potential urological applications of botulinum toxin A","volume":"12","author":"Jiang","year":"2015","journal-title":"Nat Rev Urol"},{"issue":"7","key":"10.1016\/j.smrv.2025.102181_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14070498","article-title":"Clinical application of botulinum neurotoxin in lower-urinary-tract diseases and dysfunctions: where are we now and what more can we do?","volume":"14","author":"Kuo","year":"2022","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.smrv.2025.102181_bib95","first-page":"194","article-title":"Botox for sleep effectiveness","volume":"31","author":"Getaneh","year":"2025","journal-title":"Urogynecology (Philadelphia, Pa)"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib96","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.smrv.2025.102181_bib97","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.smrv.2025.102181_bib98","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/156720110793566317","article-title":"Botulinum A toxin intravesical injections for painful bladder syndrome: impact upon pain, psychological functioning and quality of life","volume":"7","author":"Giannantoni","year":"2010","journal-title":"Curr Drug Deliv"},{"issue":"6","key":"10.1016\/j.smrv.2025.102181_bib99","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.pharep.2018.08.002","article-title":"Clinical outcomes of intravesical injections of botulinum toxin type A in patients with refractory idiopathic overactive bladder","volume":"70","author":"Juszczak","year":"2018","journal-title":"Pharmacol Rep : PR"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s13311-021-01019-4","article-title":"Restless legs syndrome: contemporary diagnosis and treatment","volume":"18","author":"Gossard","year":"2021","journal-title":"Neurotherapeutics : J Am Soc Exper NeuroTherapeut"},{"key":"10.1016\/j.smrv.2025.102181_bib101","article-title":"New concepts in the management of restless legs syndrome","volume":"356","author":"Garcia-Borreguero","year":"2017","journal-title":"Br Med J"},{"issue":"11","key":"10.1016\/j.smrv.2025.102181_bib102","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/00207454.2011.602774","article-title":"Pilot trial of onabotulinumtoxina (Botox) in moderate to severe restless legs syndrome","volume":"121","author":"Agarwal","year":"2011","journal-title":"Int J Neurosci"},{"issue":"10","key":"10.1016\/j.smrv.2025.102181_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10100401","article-title":"Botulinum toxin in restless legs Syndrome-A randomized double-blind placebo-controlled crossover Study","volume":"10","author":"Mittal","year":"2018","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.11607\/jop.921","article-title":"Epidemiology of bruxism in adults: a systematic review of the literature","volume":"27","author":"Manfredini","year":"2013","journal-title":"J Orofac Pain"},{"issue":"3","key":"10.1016\/j.smrv.2025.102181_bib105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00784-017-2092-4","article-title":"Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review","volume":"21","author":"Canales","year":"2017","journal-title":"Clin Oral Invest"},{"issue":"5","key":"10.1016\/j.smrv.2025.102181_bib106","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcms.2023.05.005","article-title":"Clinical investigation of botulinum toxin (prabotulinumtoxin A) for bruxism related to masseter muscle hypertrophy: a prospective study","volume":"51","author":"Jung","year":"2023","journal-title":"J cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery"},{"issue":"3","key":"10.1016\/j.smrv.2025.102181_bib107","first-page":"291","article-title":"Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: a polysomnographic evaluation","volume":"10","author":"Shim","year":"2014","journal-title":"J Clin Sleep Med : JCSM : Official Pub Am Acad Sleep Med"},{"issue":"7","key":"10.1016\/j.smrv.2025.102181_bib108","doi-asserted-by":"crossref","first-page":"E559","DOI":"10.1212\/WNL.0000000000004951","article-title":"Onabotulinum toxin-A injections for sleep bruxism: a double-blind, placebo-controlled study","volume":"90","author":"Ondo","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib109","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2022-000328","article-title":"Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study","volume":"4","author":"Cruse","year":"2022","journal-title":"BMJ neurology open"},{"issue":"8","key":"10.1016\/j.smrv.2025.102181_bib110","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.sdentj.2021.07.001","article-title":"Botulinum toxin and occlusal splints for the management of sleep bruxism in individuals with implant overdentures: a randomized controlled trial","volume":"33","author":"Ali","year":"2021","journal-title":"Saudi Dental J"},{"key":"10.1016\/j.smrv.2025.102181_bib111","volume":"vol. 12","author":"Perlis","year":"2021"},{"key":"10.1016\/j.smrv.2025.102181_bib112","doi-asserted-by":"crossref","first-page":"A465","DOI":"10.1093\/sleep\/zsaa056.1212","article-title":"Obstructive sleep apnea due to oromandibular dystonia and treated with botulinum toxin","volume":"43","author":"Caleb","year":"2020","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib113","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaad.2019.11.042","article-title":"Botulinum toxin: pharmacology and injectable administration for the treatment of primary hyperhidrosis","volume":"82","author":"Nawrocki","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.smrv.2025.102181_bib114","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9110365","article-title":"Botulinum toxin in management of limb tremor","volume":"9","author":"Zakin","year":"2017","journal-title":"Toxins"},{"issue":"7","key":"10.1016\/j.smrv.2025.102181_bib115","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40265-024-02048-x","article-title":"Botulinum Toxin-A for the treatment of myogenous temporomandibular disorders: an umbrella review of systematic reviews","volume":"84","author":"De la Torre Canales","year":"2024","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.smrv.2025.102181_bib116","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/CM9.0000000000001903","article-title":"Botulinum toxin in the treatment of raynaud phenomenon in patients with systemic sclerosis: a systemic review","volume":"135","author":"Cai","year":"2022","journal-title":"Chin Med J"},{"issue":"3","key":"10.1016\/j.smrv.2025.102181_bib117","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/00016489309135834","article-title":"Botulinum A toxin effects on rat jaw muscle spindles","volume":"113","author":"Filippi","year":"1993","journal-title":"Acta Otolaryngol"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib118","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12264-019-00367-8","article-title":"Antidepressant-like action of single facial injection of botulinum neurotoxin A is associated with augmented 5-HT levels and BDNF\/ERK\/CREB pathways in mouse brain","volume":"35","author":"Li","year":"2019","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.smrv.2025.102181_bib119","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neulet.2016.02.020","article-title":"Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in rats","volume":"617","author":"Ibragi\u0107","year":"2016","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.smrv.2025.102181_bib120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1073858418791763","article-title":"New insights into the neurobiology of restless legs syndrome","volume":"25","author":"Ferr\u00e9","year":"2019","journal-title":"Neuroscientist : Rev J Bring Neurobi Neurol Psych"},{"issue":"1","key":"10.1016\/j.smrv.2025.102181_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11010021","article-title":"Central effects of botulinum neurotoxin-evidence from human studies","volume":"11","author":"Weise","year":"2019","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.smrv.2025.102181_bib122","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0035-1559621","article-title":"Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials","volume":"48","author":"Magid","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.smrv.2025.102181_bib123","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.parkreldis.2016.03.002","article-title":"Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: systematic review and meta-analysis","volume":"27","author":"Rodrigues","year":"2016","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.smrv.2025.102181_bib124","author":"Piraccini","year":"2025"},{"issue":"7","key":"10.1016\/j.smrv.2025.102181_bib125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1253\/circj.66.645","article-title":"Effects of right stellate ganglion block on the autonomic nervous function of the heart: a study using the head-up tilt test","volume":"66","author":"Koyama","year":"2002","journal-title":"Circ J : official J Japanese Circulat Soci"},{"issue":"5","key":"10.1016\/j.smrv.2025.102181_bib126","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.dld.2020.11.028","article-title":"Ultrasound-guided stellate ganglion block alleviates stress responses and promotes recovery of gastrointestinal function in patients","volume":"53","author":"Zhu","year":"2021","journal-title":"Dig Liver Dis : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"issue":"6","key":"10.1016\/j.smrv.2025.102181_bib127","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/annonc\/mdr478","article-title":"Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up","volume":"23","author":"Haest","year":"2012","journal-title":"Ann Oncol : offi J European Soc Med Oncol"},{"issue":"4","key":"10.1016\/j.smrv.2025.102181_bib128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0306-9877(02)00158-5","article-title":"Novel mechanism of action hypothesized for stellate ganglion block related to melatonin","volume":"59","author":"Uchida","year":"2002","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.smrv.2025.102181_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079225001340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079225001340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:32:34Z","timestamp":1778589154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079225001340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":129,"alternative-id":["S1087079225001340"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2025.102181","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin therapy for neurological disorders: Serendipitous benefits on sleep quality and underlying mechanisms","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smrv.2025.102181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102181"}}